Cleaning & Cross-Contamination Deviations – Page 3

Visual cleanliness accepted without testing during inspection – cross-contamination risk case study

The first signs of potential contamination issues typically surface during routine visual inspections of manufacturing areas and equipment. In this case, operators reported several observations that raised alarms:Click to read…

Visual cleanliness accepted without testing during inspection – regulatory observation analysis

During the inspection, several warning signals were identified indicative of a failure in compliance with Good Manufacturing Practice (GMP). The most critical symptoms included:Click to read the full article.

Carryover detected post-cleaning during investigation – regulatory observation analysis

During routine quality control checks, operators discovered traces of active pharmaceutical ingredients (APIs) in the cleaning validation samples taken post-production. Observational signals included:Click to read the full article.

Cleaning SOP deviation ignored during equipment changeover – revalidation CAPA failure

During a routine review of product quality in the sterile injectable manufacturing area, deviations were noted in the sterility test results from multiple batches produced following a significant equipment changeover.…

Residue limit exceedance during multi-product manufacturing – cross-contamination risk case study

In June 2023, during routine QC testing, operators noted that a batch of product A exhibited elevated residue levels from a cleaning agent previously used for product B. Alerts were…

Worst-case selection unjustified during inspection – regulatory observation analysis

Regulatory Insights on Unjustified Worst-case Selection During Inspection In the highly regulated pharmaceutical industry, ensuring compliance with Good Manufacturing Practices (GMP) is non-negotiable. A recent case at a mid-sized sterile…

Worst-case selection unjustified during inspection – revalidation CAPA failure

The scenario unfolded during a routine FDA inspection of a sterile manufacturing facility. Inspectors observed deviations in the cleaning validation records, particularly concerning the inadequate justification for the worst-case selection…

Carryover detected post-cleaning during inspection – cross-contamination risk case study

During a routine internal inspection, an auditor discovered residues of a previous batch on production equipment that had undergone cleaning. The observable indicators included:Click to read the full article.

Worst-case selection unjustified during multi-product manufacturing – revalidation CAPA failure

The event occurred during routine validation of cleaning procedures between the production runs of two different products within the same facility. Operators observed an unusual increase in particulate counts in…

Cleaning validation not updated after product change during investigation – regulatory observation analysis

Following a product change at a high-capacity manufacturing facility, several warning flags emerged that indicated potential issues with cleaning validation protocols. Operators observed:Click to read the full article.

Residue limit exceedance during multi-product manufacturing – revalidation CAPA failure

During routine quality assessments in a multi-product manufacturing facility, signs of potential issues often surface. Symptoms relating to residue limits can manifest through unexpected findings in analytical testing. For instance,…

Cleaning validation not updated after product change during investigation – cross-contamination risk case study

Upon initiating a routine internal audit, a quality control (QC) analyst observed that the cleaning validation documentation for a specific product was outdated. Moreover, discrepancies were noted in the batch…